FDA Inspection 1219648 — James N. DeAngelo, D.O.
The FDA completed an inspection of James N. DeAngelo, D.O. on Sep 28, 2023 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 28, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Pittsburgh, PA (United States)
Additional details
Clinical Investigator (CI)